138 related articles for article (PubMed ID: 6696762)
21. 1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB.
Hartvigsen K; Ravandi A; Harkewicz R; Kamido H; Bukhave K; Hølmera G; Kuksis A
Lipids; 2006 Jul; 41(7):679-93. PubMed ID: 17069352
[TBL] [Abstract][Full Text] [Related]
22. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
23. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.
Snyder F
Am J Physiol; 1990 Nov; 259(5 Pt 1):C697-708. PubMed ID: 2240190
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
Nishihira J; Ishibashi T; Imai Y
J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
[TBL] [Abstract][Full Text] [Related]
26. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells.
Whatley RE; Clay KL; Chilton FH; Triggiani M; Zimmerman GA; McIntyre TM; Prescott SM
Prostaglandins; 1992 Jan; 43(1):21-9. PubMed ID: 1546171
[TBL] [Abstract][Full Text] [Related]
27. Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress.
Sugatani J; Fujimura K; Miwa M; Satouchi K; Saito K
Lipids; 1991 Dec; 26(12):1347-53. PubMed ID: 1819731
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation of alkylglycerols in plant cell cultures: production of platelet activating factor and other biologically active ether lipids.
Mangold HK; Apte SS; Weber N
Lipids; 1991 Dec; 26(12):1086-92. PubMed ID: 1819691
[TBL] [Abstract][Full Text] [Related]
29. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
30. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2001 Jun; 66(6):658-61. PubMed ID: 11421815
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro.
Camoratto AM; Grandison L
Endocrinology; 1989 Mar; 124(3):1502-6. PubMed ID: 2917522
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.
Doebber TW; Wu MS
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7557-61. PubMed ID: 3478712
[TBL] [Abstract][Full Text] [Related]
35. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain.
Tokumura A; Kamiyasu K; Takauchi K; Tsukatani H
Biochem Biophys Res Commun; 1987 May; 145(1):415-25. PubMed ID: 3593346
[TBL] [Abstract][Full Text] [Related]
36. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells.
Mueller HW; Nollert MU; Eskin SG
Biochem Biophys Res Commun; 1991 May; 176(3):1557-64. PubMed ID: 2039529
[TBL] [Abstract][Full Text] [Related]
38. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).
Blank ML; Lee T; Fitzgerald V; Snyder F
J Biol Chem; 1981 Jan; 256(1):175-8. PubMed ID: 7451433
[TBL] [Abstract][Full Text] [Related]
39. 1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.
Stoll LL; Figard PH; Yerram NR; Yorek MA; Spector AA
Cell Regul; 1989 Nov; 1(1):13-25. PubMed ID: 2519612
[TBL] [Abstract][Full Text] [Related]
40. Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs.
Kramp W; Pieroni G; Pinckard RN; Hanahan DJ
Chem Phys Lipids; 1984 May; 35(1):49-62. PubMed ID: 6744496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
